Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
PUT
GoDaddy
GDDY
$11.3B
| $917K | ﹤0.01% |
13,500
-800
| -6% | -$52.9K |
|
3702
CALL
Tenet Healthcare
THC
$20.9B
| $917K | ﹤0.01% |
24,100
-24,100
| -50% | -$722K |
|
3703
BridgeBio Pharma
BBIO
$16.3B
| $916K | ﹤0.01% |
26,134
+12,431
| +91% | +$345K |
|
|
CIVI
3704
DELISTED
Civitas Resources
CIVI
| $915K | ﹤0.01% |
39,207
-4,141
| -10% | -$81.9K |
|
|
PS
3705
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $915K | ﹤0.01% |
53,161
-2,089
| -4% | -$35.5K |
|
3706
CALL
Huazhu Hotels Group
HTHT
$13.1B
| $914K | ﹤0.01% |
22,800
+8,600
| +61% | +$310K |
|
3707
PUT
Zoetis
ZTS
$32.4B
| $913K | ﹤0.01% |
6,900
+5,600
| +431% | +$696K |
|
|
BREW
3708
DELISTED
Craft Brew Alliance, Inc.
BREW
| $911K | ﹤0.01% |
55,249
+49,346
| +836% | +$616K |
|
3709
Tredegar Corp
TG
$270M
| $910K | ﹤0.01% |
40,758
+10,780
| +36% | +$226K |
|
3710
1-800-Flowers.com
FLWS
$265M
| $909K | ﹤0.01% |
62,694
-27,944
| -31% | -$380K |
|
3711
Liberty Latin America Class A
LILA
$1.72B
| $909K | ﹤0.01% |
73,635
-8,070
| -10% | -$93.8K |
|
3712
Fastly Inc
FSLY
$3.66B
| $907K | ﹤0.01% |
45,184
+37,483
| +487% | +$790K |
|
|
FOCS
3713
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $904K | ﹤0.01% |
30,663
+14,527
| +90% | +$371K |
|
3714
Tenable Holdings
TENB
$3.92B
| $903K | ﹤0.01% |
37,673
+9,887
| +36% | +$241K |
|
|
AUY
3715
CALL
DELISTED
Yamana Gold, Inc.
AUY
| $902K | ﹤0.01% |
228,400
+15,500
| +7% | +$54.4K |
|
3716
PUT
Nutrien
NTR
$31.7B
| $901K | ﹤0.01% |
18,800
+11,500
| +158% | +$556K |
|
3717
PagerDuty
PD
$861M
| $901K | ﹤0.01% |
38,531
+17,260
| +81% | +$424K |
|
3718
German American Bancorp
GABC
$1.91B
| $899K | ﹤0.01% |
25,236
+11,079
| +78% | +$371K |
|
3719
PUT
Suncor Energy
SU
$72.7B
| $899K | ﹤0.01% |
27,400
-13,100
| -32% | -$409K |
|
3720
Alaunos Therapeutics
TCRT
$4.88M
| $898K | ﹤0.01% |
1,269
+101
| +9% | +$69.5K |
|
|
ATRS
3721
DELISTED
Antares Pharma, Inc.
ATRS
| $897K | ﹤0.01% |
190,986
+90,830
| +91% | +$372K |
|
3722
CALL
America Movil
AMX
$71.9B
| $896K | ﹤0.01% |
56,000
-28,900
| -34% | -$452K |
|
3723
Tilray
TLRY
$601M
| $896K | ﹤0.01% |
5,230
+5,060
| +2,976% | +$1.05M |
|
|
RVNC
3724
DELISTED
Revance Therapeutics, Inc.
RVNC
| $896K | ﹤0.01% |
55,227
+18,944
| +52% | +$294K |
|
3725
CALL
iShares MSCI Germany ETF
EWG
$1.61B
| $894K | ﹤0.01% |
30,400
-34,900
| -53% | -$995K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.